التفاصيل البيبلوغرافية
| العنوان: |
LBA54 Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): Results of the randomized phase II INTEGA trial (AIO STO 0217) |
| المؤلفون: |
Stein, A., Paschold, L., Tintelnot, J., Goekkurt, E., Thuss-Patience, P.C., Lorenzen, S., Ettrich, T.J., Knorrenschild, J. Riera, Jacobasch, L., Kretzschmar, A., Kubicka, S., Al-Batran, S-E., Reinacher-Schick, A., Pink, D., Sinn, M., Lindig, U., Hinke, A., Hegewisch Becker, S., Binder, M. |
| المصدر: |
In Annals of Oncology September 2021 32 Supplement 5:S1331-S1331 |
| قاعدة البيانات: |
ScienceDirect |
